We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress America 2024!
THE LARGEST DRUG SAFETY EVENT IN THE WORLD
The World Drug Safety Congress Americas convenes top executives and key stakeholders in the biopharmaceutical sector to address critical issues in drug safety, pharmacovigilance, and medical device safety.
Our team of experts is excited to participate in discussions on optimising data management and signal detection strategies, leveraging AI and machine learning to enhance pharmacovigilance processes, tackling the challenges of formulating a pharmacovigilance strategy for advanced therapies, and collaborating on effective safety strategies for medical devices.
We extend a warm invitation to attend the insightful presentation by our Chief Strategy Officer, Martin Holm-Petersen:
Topic: “Future-proofing pharmacovigilance: governance, data collection and analyses for global success.”
When: 11:30pm, Tuesday 29th October
To schedule a meeting with our team and discover how Qinecsa’s scientific proficiency and innovative technologies significantly enhance drug safety data capture, management, and evaluation with heightened efficiency and accuracy.
For an overview of the event agenda, please visit the official World Drug Safety Congress Americas 2024 event website.
We are excited to join the World Drug Safety Congress Americas 2024, where global industry leaders will confront critical challenges in drug safety. This event provides us with the opportunity to showcase how our innovative technology and scientific expertise deliver solutions that directly address these challenges, enabling life science companies to achieve the highest standards in drug safety.
We look forward to seeing you there!
